Corient Private Wealth
PRTK

Corient Private Wealth’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Corient Private Wealth’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,550
Closed -$34.4K – 2238
2023
Q2 		$34.4K Hold
15,550
– – ﹤0.01% 2021
2023
Q1 		$39.5K Hold
15,550
– – ﹤0.01% 1940
2022
Q4 		$29.1K Buy
+15,550
New +$29.1K ﹤0.01% 1653